Clincosm LogoSign in Get a demo

stage iv nasopharyngeal carcinoma

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx

Active, not recruiting
Has Results
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2022

Epstein-Barr Virus Positive, Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma Trial (Durvalumab,

Withdrawn
  • Epstein-Barr Virus Positive
  • +6 more
  • (no location specified)
Oct 22, 2020

Stage 0 Nasopharyngeal Carcinoma, Stage 0 Paranasal Sinus Cancer, Stage I Nasopharyngeal Carcinoma Trial in Palo Alto

Terminated
  • Stage 0 Nasopharyngeal Carcinoma
  • +17 more
  • Physiologic Testing
  • +8 more
  • Palo Alto, California
    Stanford University, School of Medicine
Feb 1, 2019

Stage IV Gastric Carcinoma, Stage IV Nasopharyngeal Carcinoma, T-Cell Lymphoma Stage IV Trial in Nanjing (Fludarabine,

Unknown status
  • Stage IV Gastric Carcinoma
  • +4 more
  • Nanjing, Jiangsu, China
  • +1 more
Apr 28, 2017

Stage IV Nasopharyngeal Carcinoma Trial in Guangzhou (cisplatin and 5-Fu combined with nimotuzumab)

Completed
  • Stage IV Nasopharyngeal Carcinoma
  • cisplatin and 5-Fu combined with nimotuzumab
  • Guangzhou, Guangdong, China
    Cancer Center, Sun Yat-sen University
Sep 19, 2015

Stage IV Nasopharyngeal Carcinoma Trial in Guangzhou city (GC chemo plus CIK cells (Gemcitabine, Cisplatin, Autologous CIK

Unknown status
  • Stage IV Nasopharyngeal Carcinoma
  • GC chemotherapy plus CIK cells (Gemcitabine, Cisplatin, Autologous CIK cells)
  • GC chemotherapy (Gemcitabine, Cisplatin)
  • Guangzhou city, Guangdong, China
    Cancer Center, Sun Yat-sen University
Aug 1, 2012